norovirus vaccine

When it comes to clinical trials of a norovirus vaccine – something that has been ongoing since the 1970s, it's the Wild West. The early vaccines were crude and the outcomes has been universally dismal.

For many years, norovirus vaccine (NoV) research has been going gangbusters but with nothing to show. NoV is one of the primary culprits behind acute gastroenteritis worldwide.

Ask anyone, whether it's a librarian, vegetarian, Hungarian, or a dromedarian (yes, I made that up), or anyone else, where the first successful method of preventing norovirus (aka "stomach flu") infections might come from,

As if winter isn't bad enough. Perhaps a visit from Santa might cheer you up, especially if you've already had a visit from Satan (note the brilliant juxtaposition of letters!).

This past April I reported that Vaxart, a small San Francisco vaccine biotech, was ready to start dosing volunteers with its experimental vaccine against norovirus, aka, the stomach flu, in Phase Ib studies (See